AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Nieuwkerk, P Gisolf, E Sprangers, M Danner, S
Citation: P. Nieuwkerk et al., Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response, ANTIVIR TH, 6(2), 2001, pp. 97-103

Authors: Danner, S Belasco, JG
Citation: S. Danner et Jg. Belasco, T7 phage display: A novel genetic selection system for cloning RNA-bindingproteins from cDNA libraries, P NAS US, 98(23), 2001, pp. 12954-12959

Authors: Sommer, B Barbieri, S Hofele, K Wiederhold, KH Probst, A Mistl, C Danner, S Kauffmann, S Spooren, W Tolnay, M Bilbe, G Van der Putten, H
Citation: B. Sommer et al., Lewy-like pathology in mice transgenic for mutant (A53T) and wild-type human alpha-synuclein, ALZHEIMER'S DISEASE, 2001, pp. 661-670

Authors: Sommer, B Barbieri, S Hofele, K Wiederhold, KH Probst, A Mistl, C Danner, S Kauffmann, S Spooren, W Tolnay, M Bilbe, G van der Putten, H Kafmann, S Caromi, P Ruegg, MA
Citation: B. Sommer et al., Mouse models of alpha-synucleinopathy and Lewy pathology, EXP GERONT, 35(9-10), 2000, pp. 1389-1403

Authors: van der Putten, H Wiederhold, KH Probst, A Barbieri, S Mistl, C Danner, S Kauffmann, S Hofele, K Spooren, WPJM Ruegg, MA Lin, S Caroni, P Sommer, B Tolnay, M Bilbe, G
Citation: H. Van Der Putten et al., Neuropathology in mice expressing human alpha-synuclein, J NEUROSC, 20(16), 2000, pp. 6021-6029

Authors: ElSohly, HN Danner, S Li, XC Nimrod, AC Clark, AM
Citation: Hn. Elsohly et al., New antimycobacterial saponin from Colubrina retusa, J NAT PROD, 62(9), 1999, pp. 1341-1342

Authors: Abrams, D Allan, D Antunes, F Breckenridge, A Bruun, J Cameron, W Carbon, C Chalmers, I Chang, H Chodakewitz, J Clendenin, N Clumeck, N Collier, A Collins, G Cooper, E Cooper, D Danner, S D'Aquila, R DeGruttola, V DeMasi, R Dee, L Deyton, L Dixon, D Farthing, C Feinberg, J Fischl, M Flepp, M Gartland, M Gatell, J Gazzard, B Goebel, F Gotzsche, P Gringeri, A Hall, D Hamilton, J Hammer, S Hartigan, P Heath-Chiozzi, M Henry, K Hill, A Hirschel, B Ioannidis, J Kahn, J Katlama, C Katzenstein, D Killen, J King, E de Loes, SK Kravcik, S Lange, J Leavitt, R Leonard, J Maeland, A Mannucci, P Mathiesen, L McDade, H Meibohn, A Melander, H Merigan, T Mulder, J Myers, M Neaton, J Nessling, M Perrin, L Pettinelli, C Phair, J Phillips, A Pinching, A Poppa, A Power, L Reiss, P Richman, D Rooney, J Rousseau, F Rutherford, G Salgo, M Sandstrom, E Saravolatz, L Savidge, G Schnittman, S Schooley, R Seligmann, M Simberkoff, M Skowron, G Slade, P Smith, D Smith, RP Soriano, V Stanley, K Stingl, G Stoffels, P Struthers, L Tierney, C Thompson, M Van der Broeck, R Van Leeuven, R Van Weverling, G Veenstra, J Vella, S Volberding, P Weber, J Winslow, D Yeni, P Yeo, J Dormont, J Sande, M Weller, I Babiker, A Collins, R Darbyshire, J Duncan, W Foulkes, M Hughes, M Peto, R Peto, T Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025

Authors: Plate, KH Beck, H Danner, S Allegrini, PR Wiessner, C
Citation: Kh. Plate et al., Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct, J NE EXP NE, 58(6), 1999, pp. 654-666

Authors: Koot, M van Leeuwen, R de Goede, REY Keet, IPM Danner, S Schattenkerk, JKME Reiss, P Tersmette, M Lange, JMA Schuitemaker, H
Citation: M. Koot et al., Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis, J INFEC DIS, 179(1), 1999, pp. 254-258

Authors: Bastian, LS Kwiatkowski, BA Breininger, J Danner, S Roth, G
Citation: Ls. Bastian et al., Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenicEts transcription factor Fli-1, BLOOD, 93(8), 1999, pp. 2637-2644
Risultati: 1-10 |